YOLFTbeta
67

Lagis Enterprise Co., Ltd.

6730 · TWO · Healthcare / Medical Instruments & Supplies

31.50TWD+0.50 (+1.61%)

Price History

Full chart

Market Stats

Previous Close31.00
Open31.00
Day Range31.00 – 31.50
52-Week Range31.50 – 50.12
Volume3.03K
Market Cap1.16B
P/E (TTM)16.14
Forward P/E0.00
EPS1.98
Dividend Yield4.69%
Beta0.20
50-Day Avg33.03
200-Day Avg35.95

About

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China. Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port kit for TAMIS, and advanced single port device for vNOTES; path cap and shield wound reactors; energy bipolar forceps; suction irrigation systems and irrigation pumps; electrosurgery system; endo endoscopic instruments, include scissors and dissectors, graspers, mini laparoscopy grasping device, and laparoscopic electrode; and retrieval specimen bags. The company sells its products under LAGIS brand name. Lagis Enterprise Co., Ltd. was founded in 2004 and is headquartered in Taichung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Zhenghong Chen
  • HeadquartersNo.29, Gong 1st Road, Taichung, Taiwan, 437101, Taiwan
  • Websitehttps://www.lagis.com.tw

Leadership

  • Mr. Zhenghong ChenRepresentative Chairman, CEO and Head of R&D and Sales Departments
  • Mr. Wenguo QiuManagement Manager, Head of Finance, Head of Corporate Governance Accounting Supervisor
  • Mr. Zhengxiong ChenGM & Representative Director

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue406.53M319.36M393.04M442.19M459.93M454.36M487.65M
Growth (%)--21.44%+23.07%+12.50%+4.01%-1.21%+7.33%
Cost of Revenue189.05M180.68M214.76M219.31M241.05M232.94M251.45M
Gross Profit217.49M138.68M178.28M222.88M218.89M221.42M236.20M
Gross Margin53.50%43.42%45.36%50.40%47.59%48.73%48.44%
Operating Expense105.16M98.15M116.98M134.04M141.78M140.21M148.30M
Operating Income112.33M40.53M61.30M88.84M77.10M81.21M87.90M
Operating Margin27.63%12.69%15.60%20.09%16.76%17.87%18.02%
EBITDA136.52M67.82M92.31M120.58M112.36M116.97M132.19M
EBITDA Margin33.58%21.24%23.49%27.27%24.43%25.74%27.11%
Net Income89.16M32.32M48.94M71.04M64.11M68.24M69.27M
Net Income Margin21.93%10.12%12.45%16.06%13.94%15.02%14.20%
R&D36.67M40.44M47.91M62.00M58.93M56.35M59.94M
R&D as % of Total Revenue9.02%12.66%12.19%14.02%12.81%12.40%12.29%
Interest Expense226.00K199.00K120.00K124.00K68.00K55.00K2.85M
Interest Expense % of Total Revenue0.06%0.06%0.03%0.03%0.01%0.01%0.58%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets587.46M538.07M594.07M658.75M845.39M1.09B1.14B
Total Liabilities102.26M66.21M98.89M124.49M304.62M506.34M377.35M
Total Equity485.19M471.86M495.18M534.26M540.77M579.80M761.99M
Cash150.65M114.75M150.74M128.52M89.86M69.20M95.29M
Total Debt3.99M2.79M10.13M9.03M177.66M394.37M-
Net Debt-146.65M-111.95M-140.61M-119.49M87.80M325.17M171.85M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow109.80M29.80M96.24M84.27M77.49M74.06M131.68M
Investing Cash Flow-11.29M-17.13M-29.52M-69.75M-226.00M-275.80M-
Financing Cash Flow-24.77M-48.63M-30.71M-36.77M109.89M181.03M-
Capital Expenditure10.52M17.41M29.52M69.93M226.00M276.12M92.04M
Free Cash Flow99.28M12.39M66.72M14.34M-148.51M-202.05M39.64M
Dividends Paid50.47M45.72M25.60M32.00M57.60M32.00M32.08M
FCF to OCF90.42%41.58%69.33%17.02%-191.65%-272.81%30.10%
Dividend Paid to FCF50.84%369.00%38.37%223.16%-38.79%-15.84%80.93%

Key Statistics & Ratios

Market Cap1.16B
Enterprise Value1.32B
Trailing P/E16.14
Forward P/E0.00
Price / Sales2.36
Price / Book1.58
EPS1.98
Book Value20.38
Revenue (TTM)492.35M
Gross Profit (TTM)229.20M
EBITDA131.61M
Profit Margin13.95%
Operating Margin14.91%
Return on Equity10.41%
Return on Assets4.48%
Shares Outstanding36.30M
Shares Float16.90M
Beta0.20
Dividend Yield4.69%
Dividend Rate1.50
Payout Ratio126.26%

Dividends

20261×
1.50Jul 6, 2026
20251×
1.00Jul 17, 2025
20241×
1.00Jul 18, 2024
20231×
1.80Jul 26, 2023
20221×
1.00Jul 21, 2022
20211×
0.80Aug 2, 2021
20201×
1.50Aug 26, 2020

Stock Splits

  • Aug 26, 20201050:1000